Ritonavir-boosted ARV linked to adrenal dysfunction in babies

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2011年 / 1360卷 / 1期
关键词：
Zidovudine; Ritonavir; Congenital Adrenal Hyperplasia; Lopinavir; 17OHP Level;
D O I：
10.2165/00128415-201113600-00001
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [21] Clinical Effectiveness of Ritonavir-Boosted Nirmatrelvir-A Literature Review
    Paltra, Sydney
    Conrad, Tim O. F.
    ADVANCES IN RESPIRATORY MEDICINE, 2024, 92 (01) : 66 - 76
  • [22] Tipranavir: A Ritonavir-Boosted Protease InhibitorA Viewpoint by Charles Hicks
    Charles Hicks
    Drugs, 2005, 65 : 1678 - 1678
  • [23] Ritonavir-boosted protease inhibitors: Impact of ritonavir on toxicities in treatment-experienced patients
    Sension, Michael
    Piliero, Peter J.
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2007, 18 (01): : 36 - 47
  • [24] Effectiveness of ritonavir-boosted protease inhibitor monotherapy in routine practice
    Fonquernie, L.
    Lefebvre, B.
    Valin, N.
    Morand-Joubert, L.
    Boyd, A.
    Meynard, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 155 - 155
  • [25] Delavirdine increases drug exposure of ritonavir-boosted protease inhibitors
    Harris, M
    Alexander, C
    O'Shaughnessy, M
    Montaner, JSG
    AIDS, 2002, 16 (05) : 798 - 799
  • [26] Transplacental passage of ritonavir-boosted darunavir in two pregnant women
    Ripamonti, D.
    Cattaneo, D.
    Cortinovis, M.
    Maggiolo, F.
    Suter, F.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2009, 20 (03) : 215 - 216
  • [27] HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review
    Bierman, Wouter F. W.
    van Agtmael, Michiel A.
    Nijhuis, Monique
    Danner, Sven A.
    Boucher, Charles A. B.
    AIDS, 2009, 23 (03) : 279 - 291
  • [28] LONG-TERM SAFETY OF A DUAL REGIMEN OF RALTEGRAVIR AND RITONAVIR-BOOSTED PROTEASE INHIBITOR IN ARV-EXPERIENCED PATIENTS WITH CHRONIC KIDNEY DISEASE
    Segala, D.
    Roda, R.
    Libanore, M.
    Sighinolfi, L.
    INFECTION, 2011, 39 : S76 - S76
  • [29] Neurocognitive and neurometabolic effects of switch from efavirenz to ritonavir-boosted lopinavir
    Payne, B.
    Chadwick, T.
    Blamire, A.
    Qian, J.
    Hynes, A. M.
    Wilkinson, J.
    Price, D. A.
    Anderson, K.
    HIV MEDICINE, 2016, 17 : 41 - 41
  • [30] Pharmacokinetics of coadministered ritonavir-boosted elvitegravir and zidovudine, didanosine, stavudine, or abacavir
    Ramanathan, Srinivasan
    Shen, Gong
    Hinkle, John
    Enejosa, Jeffrey
    Kearney, Brian P.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (02) : 160 - 166
12345